Cancer research is a major strategic area of the
University of Zurich (UZH) and the
University Hospital Zurich (USZ). Together, UZH and USZ have recently established the Comprehensive Cancer Center Zurich (CCC ZURICH) uniting innovative cancer research and cancer patient care. In collaboration with numerous academic and industry partners the CCC ZURICH forms an interdisciplinary cancer network in Zurich.
Within the CCC ZURICH, the Cancer Research Center (CRC) aims to integrate and support cancer research activities of the UZH, USZ, Children`s Hospital,
Balgrist University Hospital and
Swiss Federal Institute of Technology Zurich (ETH). As an interdisciplinary research platform, it facilitates cutting edge research on the molecular and cellular mechanisms of cancer, the establishment of novel preclinical disease models, the development of innovative technologies and the pre-clinical testing of novel therapeutic approaches.
To further develop outstanding cancer research, the UZH and Medical Faculty have established the competitive CRC Funding Program (CHF 4.9 Mio, 2018-2021). The program supports multidisciplinary, translational research projects of UZH/USZ scientists and physician-scientists and is a pivotal instrument for the strategic development of the CRC research programs.
Dedicated research programs for Tumor Immunology, (Epi)Genetics & Genomics, Oncogenic Signaling and Imaging & Technology Development streamline and facilitate the translation of scientific discoveries into clinical application. The overall aim is to make breakthrough discoveries in basic and clinical cancer research and develop those into novel diagnostic procedures and therapeutic interventions for adults and children with cancer to ultimately improve cancer patient care.